The 2004 Women and HIV Think Tank surpassed expectations by achieving all of its stated objectives as well as develping additional opportunities for collaboration and advocacy. This Think Tank meeting was the second annual gathering of the Women and HIV Think Tank Initiative, conceived by The Well Project in 2002 (later to become the Women's Research Initiative in 2005). Building on the 2003 Think Tank, the purpose of the 2004 meeting was to design and launch an action plan for coordinating a multi-disciplinarry effort to develop, track and enhance research on HIV disease in women. This year, participants evaluated three major areas of focus that were identified as critical by the 2003 Think Tank: generating and disseminating a research agenda that addresses women's issues, enhancing the participation of women in research and tracking progress of research on HIV disease in women.
The 2004 Think Tank meeting included 30 individuals representing research institutions, clinics, government agencies, advocacy organizations, and pharmaceutical companies. By engaging this diverse group of thought-leaders in a rigorous brainstorming process in full group and breakout group formats, a strong consensus emerged on the need for a coordinated action and specific plans to proceed. A list of the 2004 Women and HIV Think Tank participants can be found below.
For the full 2004 meeting report, please click the link below.
2004 Women and HIV Think Tank Participants
Judith D. Auerbach, PhD
Vice President, Public Policy
amfAR
Dawn Averitt Bridge
Founder
The Well Project
Arlene Bardeguez, MD, MPH, FACOG
Associate Professor, Director HIV
New Jersey Medical School, Department of OB-GYN
Julie Barroso, PhD, ANP, CS
Assistant Professor
Duke University School of Nursing
Karen Beckerman, MD
Chair, Department of OB-GYN
Newark Beth Israel Medical Center
Carol Brosgart, MD
Vice President, Clinical Research
Gilead Sciences
Gina Brown, MD
Medical Director
Cicatelli Associates, Inc.
Victoria Cargill, MD, MSCE
Director of Minority Research
National Institutes of Health
Rebecca Clark, MD
Associate Professor of Medicine
Louisiana State University Health Sciences Center
Susan Cohn, MD, MPH
Associate Professor of Medicine
University of Rochester Medical Center
Elaine M. Daniels, MD, PhD
Senior Medical Director
Therapeutic Group Leader for HIV & Women's Health
Pfizer, Inc.
Jane Hitti, MD
University of Washington Medical Center
Tina Kanmaz, PharmD
Clinical Scientist
Abbott Virology
Ben Kozub
Associate Product Manager, Viramune
Boehringer Ingelheim
Sharon Lee, MD
Southwest Boulevard Family Health Care Center
Martin Lewis, M.Ed., MSN, RNCS, ANP, ACRN
Associate Director, Community Relations
Gilead Sciences
Veronica Miller, PhD
Director
Forum for Collaborative HIV Research
Donne Newbury, PhD
Bristol-Myers Squibb
Karin Nielsen, MD, MPH
Associate Clinical Professor, Pediatric Infectious Diseases
UCLA Department of Pediatrics
Nancy Norman, MD, MPH
Director of Women's Health
Fenway Community Health
Keri Oberg
National Manager, HIV Community Relations
Boehringer Ingelheim
Andrew Pavia, MD
Professor of Pediatrics and Medicine
University of Utah
Tonia Poteat, PA-C
Grady Infectious Disease Program
Patricia Reichelderfer, PhD
Microbiologist
NIH/NICHD
Stephen Storfer, MD
Associate Director, Virology
Clinical and Scientific Affairs
Boehringer Ingelheim Pharmaceuticals, Inc.
Melanie Thompson, MD
Principal Investigator
AIDS Research Consortium of Atlanta
Jennifer VanHorn, MD
Department of OB-GYN
University of Utah
Fulvia Veronese, PhD
Chair, Etiology and Pathogenesis and Microbicides Research
National Institutes of Health
Meeting Staff
Richard Averitt
Chief Operating Officer
The Well Project
Megan Raspa
Project Manager
The Well Project
Facilitators
Rachel Conerly
Ron Wilder
Aligned Action, Inc.
Meeting Planners
Debbie Cooke
VP, Chief Operations Officer
Meeting Masters, Inc.
Tina DeRenzis
President
Meeting Masters, Inc.
